Primary GBM frequently exhibits epidermal growth factor receptor (EGFR) over expression, PTEN (MMC-I) mutation or deletion, CDKN2A (p16) deletion, and MDM2 amplification. The gene discussed is EGFR; the disease is glioblastoma.